Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Novartis
Novartis
Genmab
Genmab
Pfizer
Galapagos NV
Monte Rosa Therapeutics, Inc
Tanabe Pharma Corporation
University of Michigan Rogel Cancer Center
Incyte Corporation
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Incyte Corporation
Bambino Gesù Hospital and Research Institute
Immunitas Therapeutics
University of Washington
Ohio State University Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Sichuan Baili Pharmaceutical Co., Ltd.
Institut Curie
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Peter MacCallum Cancer Centre, Australia
Shanghai Blueray Biopharma Co., Ltd.
Academic and Community Cancer Research United